◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Sigachi Industries Limited (SIGACHI) Financial History

Name: Sigachi Industries Limited (SIGACHI) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Sigachi Industries Limited (SIGACHI) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Hyderabad, India with about 1,400 employees. Its market capitalization is roughly ₹11 billion. In the fiscal year ended 2026-03-31, SIGACHI reported ₹4.8B in revenue and (₹818M) in net income.

Sigachi Industries Limited manufactures and sells microcrystalline cellulose and cellulose powder in India. The company provides cellulose-based products under the HiCel, AceCel, CoatCel, GloCel, and BARETab brand names to pharmaceutical, nutraceutical, cosmetic, and chemical industries.

Interactive charts & full statements →

SIGACHI Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹4.8B	₹4.9B	₹4.0B	₹3.0B
Gross Profit	₹2.1B	₹2.5B	₹1.7B	₹1.4B
Operating Income (EBIT)	₹364M	₹983M	₹712M	₹526M
Net Income	(₹818M)	₹696M	₹572M	₹435M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SIGACHI Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31
Total Revenue	₹1.2B	₹1.2B	₹1.2B	₹1.3B	₹1.3B
Gross Profit	₹636M	₹625M	₹520M	₹654M	₹772M
Operating Income (EBIT)	₹121M	₹118M	₹15M	₹194M	₹238M
Net Income	₹68M	₹77M	₹2M	(₹1.0B)	₹133M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SIGACHI Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹38M)	(₹33M)	(₹31M)	(₹31M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SIGACHI Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹8.4B	₹8.5B	₹6.9B	₹3.7B	—
Total Liabilities	₹3.1B	₹2.3B	₹2.5B	₹1.1B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SIGACHI viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

AHCL · Anlon Healthcare Limited — ₹12 billion
LINCOLN · Lincoln Pharmaceuticals Limited — ₹12 billion
2627 · Ab&B Bio-Tech CO., LTD. JS — HK$12 billion
THEMISMED · Themis Medicare Limited — ₹12 billion
BAJAJHCARE · Bajaj HealthCare Limited — ₹11 billion
1681 · Consun Pharmaceutical Group Limited — HK$11 billion
4512 · Wakamoto Pharmaceutical Co.,Ltd. — JPY 10 billion
ANUHPHR · Anuh Pharma Limited — ₹9 billion

← SIGA All “S” companies SIGHT →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.